تحميل...
An unusual flare of anti-synthetase syndrome during concurrent trastuzumab therapy given for recurrent breast cancer
We present the case of a patient with relapsing anti-synthetase syndrome (ASS) that may have been triggered by monoclonal antibody trastuzumab therapy given for breast cancer. A 52-year-old female with a history of anti-Jo1-associated ASS went into remission with glucocorticoids and mycophenolate mo...
محفوظ في:
| الحاوية / القاعدة: | Eur J Rheumatol |
|---|---|
| المؤلفون الرئيسيون: | , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Medical Research and Education Association
2017
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5741342/ https://ncbi.nlm.nih.gov/pubmed/29308284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2017.17036 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|